These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3046384)

  • 21. Patterns of response during placebo treatment of panic disorder.
    Mellergård M; Rosenberg NK
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of placebo response during long-term treatment of panic disorder.
    Dager SR; Khan A; Cowley D; Avery DH; Elder J; Roy-Byrne P; Dunner DL
    Psychopharmacol Bull; 1990; 26(3):273-8. PubMed ID: 2274625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M; Lecrubier Y; Maier W; Buller R; Rosenberg R; Hippius H
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP; Pecknold JC; Kuch K
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alprazolam treatment for panic disorders.
    Alexander PE; Alexander DD
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is buspirone effective for panic disorder?
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
    Roy-Byrne PP; Dager SR; Cowley DS; Vitaliano P; Dunner DL
    Am J Psychiatry; 1989 Jul; 146(7):860-5. PubMed ID: 2742010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surreptitious drug use by patients in a panic disorder study.
    Clark DB; Taylor CB; Roth WT; Hayward C; Ehlers A; Margraf J; Agras WS
    Am J Psychiatry; 1990 Apr; 147(4):507-9. PubMed ID: 1969248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract]   [Full Text] [Related]  

  • 34. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonazepam in the treatment of patients with recurrent panic attacks.
    Beaudry P; Fontaine R; Chouinard G; Annable L
    J Clin Psychiatry; 1986 Feb; 47(2):83-5. PubMed ID: 3944069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The placebo effect in agoraphobia.
    Mavissakalian M
    J Nerv Ment Dis; 1987 Feb; 175(2):95-9. PubMed ID: 2879882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of efficacy of carbamazepine in the treatment of panic disorder.
    Uhde TW; Stein MB; Post RM
    Am J Psychiatry; 1988 Sep; 145(9):1104-9. PubMed ID: 3046381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of the Cross-National Collaborative Panic Study.
    Klerman GL
    Arch Gen Psychiatry; 1988 May; 45(5):407-12. PubMed ID: 3282477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.